AI assistant
Sending…
SIGA TECHNOLOGIES INC — Director's Dealing 2010
Oct 22, 2010
32600_dirs_2010-10-22_f891d288-fb3d-4935-a687-13d0e0419d4a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: SIGA TECHNOLOGIES INC (SIGA)
CIK: 0001010086
Period of Report: 2009-09-30
Reporting Person: MJALLI ADNAN M M (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-09-30 | Common Stock, par value $0.0001 per share ("Common Stock") | X | 1845396 | $1.8784 | Acquired | 4317618 | Indirect |
| 2009-09-30 | Common Stock | F | 444666 | $7.80 | Disposed | 3872952 | Indirect |
| 2009-09-30 | Common Stock | S | 3851969 | $6.24 | Disposed | 20983 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-09-30 | Warrant (right to buy) | $1.8784 | X | 1845396 | Disposed | 2011-01-08 | Common Stock (1845396) | Indirect |
Footnotes
F1: On September 30, 2009, TransTech Pharma, Inc. sold 3,851,969 shares of Common Stock in a privately negotiated transaction to STH Partners, L.P.
F2: The shares of Common Stock and the warrants were beneficially owned by TransTech Pharma, Inc. The reporting person is the President, Chief Executive Officer and a director of TransTech Pharma, Inc. The reporting person disclaims beneficial ownership of the securities beneficially owned by TransTech Pharma, Inc. except to the extent of his pecuniary interest therein.
More from SIGA TECHNOLOGIES INC
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Jan 28
Regulatory Filings
2025
Nov 10
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Regulatory Filings
2025
Aug 8
Interim / Quarterly Report
2025
Aug 5
Earnings Release
2025
Aug 5